Brain tumor treatment with IL-2 and IL-12 producing autologous cancer cell vaccines.
Desaknai
S
S
Department of Molecular and tumor Radiobiology, National Research Institute for Radiobiology and Radiohygiene, Budapest, Hungary.
Lumniczky
K
K
Hidvegi
E J
EJ
Hamada
H
H
Safrany
G
G
D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D001932:Brain Neoplasms / Q000276:immunology / Q000628:therapy*; D019496:Cancer Vaccines / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D005822:Genetic Vectors; D005910:Glioma / Q000276:immunology / Q000628:therapy*; D006801:Humans; D018664:Interleukin-12 / Q000096:biosynthesis* / Q000235:genetics; D007376:Interleukin-2 / Q000096:biosynthesis* / Q000235:genetics; D051379:Mice; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics; D014161:Transduction, Genetic; D014407:Tumor Cells, Cultured
D019496:Cancer Vaccines; D007376:Interleukin-2; D011994:Recombinant Proteins; D018664:Interleukin-12